Literature DB >> 23939422

Ocular biocompatibility and tolerance study of biodegradable polymeric micelles in the rabbit eye.

Lu Xu1, Xu Xu, Hao Chen, Xingyi Li.   

Abstract

Polymeric nanoparticles have been developed to improve the bioavailability of drugs applied in ocular drug delivery. However, there are few information on ocular biocompatibility of polymeric nanoparticles applied topically onto the eye. In this paper, the ocular biocompatibility and tolerance of methoxy poly(ethylene glycol)-poly(ɛ-caprolactone) (MPEG-PCL) micelles (∼50nm) were investigated in rabbit eyes after a single intracameral and intravitreal injections. In vitro cytotoxicity assays showed that MPEG-PCL micelles had no apparent cytotoxicity against human corneal epithelial cells (HCEC), human lens epithelial cells (HLEC), and retinal pigment epithelial cells (RPE cells) at micelle concentrations of 0-2mg/mL. After a single intracameral injection of 0.2mL MPEG-PCL micelles (200mg/mL) into rabbit eyes, MPEG-PCL micelles were slowly removed from aqueous humor in a period of 14 days, while the intraocular pressure (IOP) was maintained at nearly the same level for 15 days. Three days after intracameral injection, dual staining of corneal endothelium showed that the endothelial cells were nearly regular hexagon-shape with well-defined organization, similar to normal endothelial cells. Hematoxylin and eosin staining indicated that there was absence of any obvious changes in microstructure of the corneal tissue and retina after a single intracameral and intravitreal injection of 0.2mL MPEG-PCL micelles (100mg/mL, 150mg/mL, and 200mg/mL). This study provides valuable information (safety and biocompatibility) for biomedical researchers to develop MPEG-PCL micelles as candidates for ocular drug delivery.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biocompatibility; MPEG–PCL micelles; Ocular drug delivery

Mesh:

Substances:

Year:  2013        PMID: 23939422     DOI: 10.1016/j.colsurfb.2013.06.047

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  7 in total

Review 1.  Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies.

Authors:  Abhirup Mandal; Rohit Bisht; Ilva D Rupenthal; Ashim K Mitra
Journal:  J Control Release       Date:  2017-01-11       Impact factor: 9.776

2.  Effect of biometric characteristics on biomechanical properties of the cornea in cataract patient.

Authors:  Xue-Fei Song; Achim Langenbucher; Zisis Gatzioufas; Berthold Seitz; Moatasem El-Husseiny
Journal:  Int J Ophthalmol       Date:  2016-06-18       Impact factor: 1.779

Review 3.  Controlled ocular drug delivery with nanomicelles.

Authors:  Ravi D Vaishya; Varun Khurana; Sulabh Patel; Ashim K Mitra
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2014-06-02

4.  Ocular Application of Dirithromycin Incorporated Polymeric Nanoparticles: an In Vitro Evaluation.

Authors:  Ebru Başaran
Journal:  Turk J Pharm Sci       Date:  2017-08-15

Review 5.  Nanoparticles in ocular applications and their potential toxicity.

Authors:  Cao Yang; Junling Yang; Ao Lu; Jing Gong; Yuanxing Yang; Xi Lin; Minghui Li; Haiwei Xu
Journal:  Front Mol Biosci       Date:  2022-07-15

Review 6.  Insights on Development Aspects of Polymeric Nanocarriers: The Translation from Bench to Clinic.

Authors:  Akhilesh Kumar Tewari; Satish Chandra Upadhyay; Manish Kumar; Kamla Pathak; Deepak Kaushik; Ravinder Verma; Shailendra Bhatt; Ehab El Sayed Massoud; Md Habibur Rahman; Simona Cavalu
Journal:  Polymers (Basel)       Date:  2022-08-29       Impact factor: 4.967

7.  Antitumor Activity of Thermosensitive Hydrogels Packaging Gambogic Acid Nanoparticles and Tumor-Penetrating Peptide iRGD Against Gastric Cancer.

Authors:  Dinghu Zhang; Yanhong Chu; Hanqing Qian; Lingyu Qian; Jie Shao; Qiuping Xu; Lixia Yu; Rutian Li; Quanan Zhang; Fenglei Wu; Baorui Liu; Qin Liu
Journal:  Int J Nanomedicine       Date:  2020-01-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.